CM Black

474 total citations
13 papers, 347 citations indexed

About

CM Black is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, CM Black has authored 13 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in CM Black's work include Systemic Sclerosis and Related Diseases (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Eosinophilic Disorders and Syndromes (3 papers). CM Black is often cited by papers focused on Systemic Sclerosis and Related Diseases (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Eosinophilic Disorders and Syndromes (3 papers). CM Black collaborates with scholars based in United Kingdom, United States and Ireland. CM Black's co-authors include RM du Bois, AM Southcott, P. Pantelidis, R. Lawrence, D.M. Hansell, KI Welsh, Christopher Bunn, Ian C. Locke, Brian Leaker and Geraldine Cambridge and has published in prestigious journals such as The Lancet, European Respiratory Journal and Value in Health.

In The Last Decade

CM Black

13 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
CM Black United Kingdom 8 210 161 84 63 59 13 347
R Scorza Italy 8 114 0.5× 207 1.3× 42 0.5× 93 1.5× 32 0.5× 14 343
Hadi Poormoghim Iran 8 124 0.6× 277 1.7× 106 1.3× 56 0.9× 18 0.3× 17 320
Helen Spotswood United Kingdom 4 140 0.7× 161 1.0× 73 0.9× 47 0.7× 14 0.2× 7 235
Gonçalo Boleto France 10 83 0.4× 75 0.5× 47 0.6× 87 1.4× 32 0.5× 23 278
Chihiro Nishijima Japan 11 103 0.5× 307 1.9× 155 1.8× 91 1.4× 14 0.2× 15 424
Y. Allanore France 4 160 0.8× 341 2.1× 75 0.9× 102 1.6× 13 0.2× 6 379
Prodromos Hytiroglou Greece 7 41 0.2× 81 0.5× 53 0.6× 21 0.3× 59 1.0× 13 266
Kévin Didier France 6 41 0.2× 119 0.7× 55 0.7× 95 1.5× 43 0.7× 8 281
M Tokuda Japan 8 130 0.6× 29 0.2× 119 1.4× 19 0.3× 21 0.4× 15 253
Adrianne Woods United States 6 86 0.4× 110 0.7× 68 0.8× 152 2.4× 16 0.3× 10 283

Countries citing papers authored by CM Black

Since Specialization
Citations

This map shows the geographic impact of CM Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CM Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CM Black more than expected).

Fields of papers citing papers by CM Black

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CM Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CM Black. The network helps show where CM Black may publish in the future.

Co-authorship network of co-authors of CM Black

This figure shows the co-authorship network connecting the top 25 collaborators of CM Black. A scholar is included among the top collaborators of CM Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CM Black. CM Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wood, Robert, et al.. (2016). Quality of Life of Patients with Alzheimer's Disease - A Comparison with General Population. Value in Health. 19(7). A436–A436. 3 indexed citations
2.
Black, CM, et al.. (2007). Scleroderma renal crisis-patient characteristics and outcomes in 110 cases from a single centre. 3 indexed citations
3.
Nair, Devika, et al.. (2005). Value of brain natriuretic peptide in pulmonary arterial hypertension. UCL Discovery (University College London). 1 indexed citations
4.
Ponticos, Markella, et al.. (2004). Upregulation of Monocyte Chemoattractant Protein-1 in Early Stage Diffuse Scleroderma. Clinical Science. 106(s50). 11P–11P. 1 indexed citations
5.
Hazleman, B L, et al.. (2003). Woody hands. The Lancet. 361(9366). 1344–1344. 18 indexed citations
6.
Bunn, Christopher, et al.. (2001). Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. Genes and Immunity. 2(2). 76–81. 63 indexed citations
7.
Southcott, AM, et al.. (1998). Adhesion molecule expression in the lung: a comparison between normal and diffuse interstitial lung disease. European Respiratory Journal. 11(1). 91–98. 16 indexed citations
8.
Petřek, Martin, P. Pantelidis, AM Southcott, et al.. (1997). The source and role of RANTES in interstitial lung disease. European Respiratory Journal. 10(6). 1207–1216. 53 indexed citations
9.
Locke, Ian C., et al.. (1997). Autoantibodies to myeloperoxidase in systemic sclerosis.. PubMed. 24(1). 86–9. 43 indexed citations
10.
O’Connor, C. M., et al.. (1996). Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis. European Respiratory Journal. 9(5). 992–999. 35 indexed citations
11.
Majumdar, S, et al.. (1995). Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium. European Respiratory Journal. 8(2). 266–271. 45 indexed citations
12.
Hansell, D.M., et al.. (1993). Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. European Respiratory Journal. 6(6). 797–802. 65 indexed citations
13.
Black, CM, et al.. (1990). Multicentre Pilot Study of Alpha Interferon in Recent Onset Diffuse Cutaneous Scleroderma [Dcssc]. Clinical Science. 78(s22). 35P–35P. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026